Form 4: Opus Genetics Insider Sells Shares
Insider Transaction (Form 4)
Foundation Fighting Blindness Retinal Degeneration Fund and 1 other reported changes in beneficial ownership of Opus Genetics, Inc. common stock on September 30, 2026.
Summary
- Open-market sale: disposed of 556,000 Common Stock at $4.96 ($2,755,981) on September 30, 2026; holds 3,236,171 after (Direct).
Sentiment
Score: 3
Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $2,755,981 of stock on the open market.
Insider Transactions
Foundation Fighting Blindness Retinal Degeneration Fund — Director, Other (See Remarks)
Foundation Fighting Blindness, Inc. — Director, Other (See Remarks)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-30 | Open-market sale | Common Stock | 556,000 | $5 | $2.8M | 3,236,171 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-30 | Open-market sale (556,000 shares) |
Keywords
insider transaction, Form 4, IRD, Opus Genetics, Inc., bearish, Foundation Fighting Blindness Retinal Degeneration Fund, Foundation Fighting Blindness, Inc.
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.